NATCOPHARM.BONATCOPHARM.BOBSE
Loading
Year-over-year operating income growth rate
Percentile
P10
Near historical low
vs 3Y Ago
-3.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -78.64% |
| Q3 2025 | 2.61% |
| Q2 2025 | -23.09% |
| Q1 2025 | 166.57% |
| Q4 2024 | -75.97% |
| Q3 2024 | 0.15% |
| Q2 2024 | 67.21% |
| Q1 2024 | 31.13% |
| Q4 2023 | -31.55% |
| Q3 2023 | -14.03% |
| Q2 2023 | 106.74% |
| Q1 2023 | 43.65% |
| Q4 2022 | 25.69% |
| Q3 2022 | -64.83% |
| Q2 2022 | 1218.58% |
| Q1 2022 | -115.72% |
| Q4 2021 | 99.03% |
| Q3 2021 | -21.34% |
| Q2 2021 | 1884.80% |
| Q1 2021 | -107.32% |
| Q4 2020 | -64.70% |
| Q3 2020 | 67.16% |
| Q2 2020 | 10432.14% |
| Q1 2020 | -100.96% |
| Q4 2019 | 10.90% |
| Q3 2019 | -18.26% |
| Q2 2019 | 21440.00% |
| Q1 2019 | -99.58% |
| Q4 2018 | 0.67% |
| Q3 2018 | -1.82% |
| Q2 2018 | 3.13% |
| Q1 2018 | -15.80% |
| Q4 2017 | 107.66% |
| Q3 2017 | -21.32% |
| Q2 2017 | 37.92% |
| Q1 2017 | -55.62% |
| Q4 2016 | 126.64% |
| Q3 2016 | 0.82% |
| Q2 2016 | -17.51% |
| Q1 2016 | 362.04% |